» Articles » PMID: 36670451

Pathomechanisms in Central Serous Chorioretinopathy: A Recent Update

Overview
Publisher Biomed Central
Date 2023 Jan 20
PMID 36670451
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Central serous chorioretinopathy (CSCR) is a potentially blinding choroidal disease. Despite decades of research, the pathological mechanisms of CSCR are still poorly understood. In recent years, there has been a strong emphasis on choroidal dysfunction as a primary cause of CSCR.

Main Body: The concept of the pachychoroid disease spectrum and pachychoroid-driven processes are central to current theories regarding the pathophysiological underpinnings of CSCR. Choroidal hyperpermeability and subsequent leakage of fluid seen in CSCR may be due to several causes. Among them are venous congestion, inflammation, mineralocorticoid receptor activation, systemic factors including hemodynamic changes, obstructive sleep apnea, phosphodiesterase inhibitor use, pregnancy, and genetic predispositions. Congestion of vortex veins that drain blood from the choroid may contribute to the dilation of Haller vessels and cause fluid leakage. Vortex veins exit the eye through the sclera; thus, increased scleral thickness has been proposed to be a factor in venous congestion. Asymmetric vortex vein drainage may similarly result in congestion of the local venous system. Vortex vein anastomoses may overload the venous system and form secondary to venous congestion. Recent studies suggest inflammation and mineralocorticoid activation may factor into the development of CSCR, though more research in these areas is called for. Systemic conditions and genetics may predispose individuals to develop CSCR.

Conclusions: By striving to understand the molecular and physiological mechanisms of this disease, we can better diagnose and treat CSCR to improve outcomes for patients.

Citing Articles

Oscillatory photodynamic therapy in central serous chorioretinopathy.

Valsecchi N, Hasan N, Sadeghi E, Chhablani J Graefes Arch Clin Exp Ophthalmol. 2025; .

PMID: 39934352 DOI: 10.1007/s00417-025-06766-0.


Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy.

Rabinovitch D, Shulman S, Goldenberg D, Wang L, Iyer P, Loewenstein A Biomedicines. 2025; 12(12.

PMID: 39767667 PMC: 11673265. DOI: 10.3390/biomedicines12122760.


A Bibliometric Analysis of Pregnancy-Related Eye Disease from 1999 to 2022.

Yue J, Shi M, Gao M, Niu Y, Zhou S, Zhang H Matern Child Health J. 2024; 29(2):225-239.

PMID: 39585584 DOI: 10.1007/s10995-024-04017-y.


Retinal Layer and Choroidal Changes in Deep and Scuba Divers: Evidence of Pachychoroid Spectrum-Like Findings.

Demir N, Kayhan B, Acar M, Sevincli S, Sonmez M J Ophthalmol. 2024; 2024:1600148.

PMID: 39583640 PMC: 11584252. DOI: 10.1155/2024/1600148.


Importance of OCT-derived biomarkers for the recurrence of central serous chorioretinopathy using statistics and predictive modelling.

Seiler E, Delachaux L, Cattaneo J, Garjani A, Martin T, Duriez A Sci Rep. 2024; 14(1):23940.

PMID: 39397115 PMC: 11471761. DOI: 10.1038/s41598-024-75275-7.


References
1.
Lee Y, Lee Y, Lee J, Lee S . A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography. Sci Rep. 2021; 11(1):5872. PMC: 7955033. DOI: 10.1038/s41598-021-85229-y. View

2.
ORourke M . Basic concepts for the understanding of large arteries in hypertension. J Cardiovasc Pharmacol. 1985; 7 Suppl 2:S14-21. View

3.
Weenink A, Borsje R, Oosterhuis J . Familial chronic central serous chorioretinopathy. Ophthalmologica. 2001; 215(3):183-7. DOI: 10.1159/000050855. View

4.
Zola M, Mejlachowicz D, Gregorio R, Naud M, Jaisser F, Zhao M . Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues. Int J Mol Sci. 2022; 23(3). PMC: 8836134. DOI: 10.3390/ijms23031278. View

5.
Kanda P, Gupta A, Gottlieb C, Karanjia R, Coupland S, Bal M . Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye (Lond). 2021; 36(5):941-962. PMC: 9046392. DOI: 10.1038/s41433-021-01808-3. View